Shockwave therapy for Peyronie's disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, prospective trial enrolling men who present to the clinic with stable Peyronie's disease. Eligible participants who provide consent will all receive a standard extracorporeal shockwave therapy protocol. Outcomes will be measured before and after treatment using the International Index of Erectile Function-5 and a short-form quality of life questionnaire. The collected data will be analyzed statistically to determine any changes following the treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Male individuals aged 18-65 years.
* Having been diagnosed with Peyronie's Disease that has been stable (without increasing pain and curvature) for at least 6 months.
* Presence of palpable penile plaque.

Exclusion Criteria:

* Acute inflammatory stage (painful, progressive)
* Having previously undergone surgery, needle therapy (e.g., Xiaflex), or Extracorporeal Shockwave Therapy for peyronie's disease.
* Uncontrolled diabetes, severe coagulopathy, or receiving anticoagulant therapy.
* History of penile cancer.
* Severe erectile dysfunction.
* Patients who are considered unable to comply with the study protocol or who cannot attend follow-up visits.

Where it's running

• Koreya Serq Tebabeti
  Baku, Azerbaijan Recruiting

Study contacts

• Study coordinator: Ömer ŞEVGİN
• Email: omer.sevgin@uskudar.edu.tr
• Phone: +905069787535

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Cord blood platelet-rich plasma plus penile traction versus traction alone for Peyronie's disease

  This tests whether adding cord blood platelet-rich plasma injections to penile traction helps men with Peyronie's disease and significant penile curvature.

  Recruiting Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Milan · NCT07010900

• Using shockwave therapy with Xiaflex to treat Peyronie's disease

  This study is testing if combining shockwave therapy with a medication called Xiaflex can help men with Peyronie's disease improve their penile curvature better than standard treatment alone.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT06065436

• Light-targeted balance training to improve balance and reduce fear of falling

  This trial tests whether light-targeted balance training helps people with a history of falls improve balance and functional performance, and feel less afraid of falling, compared with standard balance training.

  Recruiting Uskudar University · Istanbul, Istanbul · NCT07775183

• Multichannel neuromuscular stimulation plus core exercise for chronic low back pain

  This study tests two multichannel neuromuscular electrical stimulation programs added to a core exercise plan to see if they help adults with chronic non-specific low back pain.

  Recruiting Uskudar University · Şırnak · NCT07760142

• Core endurance vs segmental stabilization for low back pain in recreational athletes

  This trial tests whether core endurance exercises or segmental stabilization exercises better help recreational athletes with non-specific low back pain.

  Recruiting Uskudar University · Istanbul · NCT07760103

• Muscle Energy Technique to improve neck function and range of motion for people with non-specific neck pain

  This study will test whether Muscle Energy Technique helps adults aged 18–65 with non-specific neck pain reduce disability and improve neck range of motion.

  Recruiting Uskudar University · Istanbul, Ataşehir · NCT07524075

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.